To access this element change to forms mode OFF
Grant Award View - GA289001
PAGETURNA: Pioneering Application of Gene Editing in Transplant Using...
GA ID:
GA289001
Agency:
Department of Health and Aged Care
Approval Date:
9-Dec-2022
Publish Date:
20-Mar-2023
Category:
Medical Research
Grant Term:
1-Feb-2023 to 31-Mar-2025
Value (AUD):
$1,077,978.00
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
DoHAC 22/23 1.1 Health Policy Research and Analysis
Grant Program:
Medical Research Future Fund
Grant Activity:
PAGETURNA: Pioneering Application of Gene Editing in Transplant Using RNA
Purpose:
We will apply cutting edge gene-editing technologies in blood stem cells, to prevent children and young adults from dying from bone marrow failure syndromes. We aim to: 1) consolidate Australian gene editing capabilities, 2) demonstrate proof-of-principle corrective gene editing in blood stem cells, 3) trial a feasible, curative, blood stem cell product, and 4) determine the clinical framework for implementation of a therapy.
GO ID:
GO Title:
MRFF – Stem Cell Therapies Mission – 2022 Stem Cell Therapies Grant Opportunity
Internal Reference ID:
2022/MRF2024395
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
St Vincent's Institute of Medical Research
Recipient ABN:
52 004 705 640
Grant Recipient Location
Suburb:
Fitzroy
Town/City:
Fitzroy
Postcode:
3065
State/Territory:
VIC
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
NSW, VIC, TAS
Postcode:
Multiple
Country:
AUSTRALIA